14‐3‐3 and β‐catenin are secreted on extracellular vesicles to activate the oncogenic Wnt pathway
Open Access
- 22 March 2014
- journal article
- Published by Wiley in Molecular Oncology
- Vol. 8 (5) , 894-911
Abstract
Aberrant activation of the canonical Wnt signal transduction pathway is involved in a large number of human diseases. β‐catenin, the key effector protein of the canonical Wnt pathway, functions in the nucleus with T‐cell factor/lymphoid enhancer factor (TCF/LEF) to activate expression of Wnt target genes. Here we show that members of the 14‐3‐3 protein family bind disheveled‐2 (Dvl‐2) and glycogen synthase‐3β (GSK‐3β) to attenuate the interaction between GSK‐3β and β‐catenin. Importantly, 14‐3‐3 and β‐catenin form “bleb‐like” structures and are secreted via extracellular vesicles to induce Wnt signaling activity in target cells. Our data suggest a novel way of transducing the oncogenic Wnt signal in which β‐catenin is regulated by 14‐3‐3ζ through the formation of “oncosomes” that contain both the 14‐3‐3 and β‐catenin proteins.Keywords
Funding Information
- Israel Science Foundation (ISF) (20120016)
This publication has 74 references indexed in Scilit:
- Carboxypeptidase E: a negative regulator of the canonical Wnt signaling pathwayOncogene, 2012
- Three decades of Wnts: a personal perspective on how a scientific field developedThe EMBO Journal, 2012
- The many faces and functions of β‐cateninThe EMBO Journal, 2012
- Endocytic control of growth factor signalling: multivesicular bodies as signalling organellesNature Reviews Molecular Cell Biology, 2011
- 14-3-3 proteins as potential therapeutic targetsSeminars in Cell & Developmental Biology, 2011
- Wnt Signaling Requires Sequestration of Glycogen Synthase Kinase 3 inside Multivesicular EndosomesCell, 2010
- Wnt/β-Catenin Signaling: Components, Mechanisms, and DiseasesDevelopmental Cell, 2009
- The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer developmentTrends in Cell Biology, 2009
- Differential mediation of the Wnt canonical pathway by mammalian Dishevelleds-1, -2, and -3Cellular Signalling, 2008
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000